Golden Finance reports that, according to PRNewswire, Synaptogenix (NASDAQ: SNPX), a biotech company listed on the US stock market, has announced the completion of its first TAO token acquisition as part of its recently disclosed cryptocurrency treasury strategy focused on artificial intelligence and machine learning. The company has chosen digital asset infrastructure provider BitGo to provide qualified custody, staking, and trading services for its TAO holdings. Synaptogenix Executive Chairman Joshua Silverman stated that under the guidance of James Altucher, the head of the crypto TAO strategy, the company has acquired the leading crypto AI token TAO and has begun staking the token to generate yield and capital appreciation. Synaptogenix has started generating yield through TAO staking, with initial acquisition funds coming from the company's ample cash reserves.

#AI